One possible mechanism of this beneficial effect is the powerful antioxidant effects that could result from enhancing the SOD levels, which are ideally higher than the negative control in both mice and HepG2 cell NAFLD-induced models, and reducing oxidative levels reflected by low MDA to similar levels compared to the ND group. This evidence concerns the gene SOD1 and metabolic dysfunction-associated steatotic liver disease.